Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis

Objective: The proposal of the present study was to investigate whether the TP53 rs1042522 polymorphism confers susceptibility to prostate cancer (PCa), by performing an updated meta-analysis. Methods: Eligible publications investigating the association between the TP53 rs1042522 polymorphism and PC...

Full description

Bibliographic Details
Main Authors: Song Fan, Zong-Yao Hao, Meng Zhang, Chao-Zhao Liang
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2017-06-01
Series:Chronic Diseases and Translational Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2095882X1630127X
id doaj-8cb703adb1514733870d26f53f53777c
record_format Article
spelling doaj-8cb703adb1514733870d26f53f53777c2021-02-02T05:33:08ZengKeAi Communications Co., Ltd.Chronic Diseases and Translational Medicine2095-882X2017-06-013295104Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysisSong Fan0Zong-Yao Hao1Meng Zhang2Chao-Zhao Liang3Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China; Institute of Urology, Anhui Medical University, Hefei, Anhui 230032, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China; Institute of Urology, Anhui Medical University, Hefei, Anhui 230032, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China; Institute of Urology, Anhui Medical University, Hefei, Anhui 230032, ChinaDepartment of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China; Institute of Urology, Anhui Medical University, Hefei, Anhui 230032, China; Corresponding author. Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China.Objective: The proposal of the present study was to investigate whether the TP53 rs1042522 polymorphism confers susceptibility to prostate cancer (PCa), by performing an updated meta-analysis. Methods: Eligible publications investigating the association between the TP53 rs1042522 polymorphism and PCa susceptibility were selected from PubMed, Google Scholar, and Web of Science. We used STATA 12.0 software to conduct the analyses. Odds ratio (OR) with 95% confidence interval (CI) was calculated. Results: A total of 17 caseâcontrol studies were retrieved reporting a total of 2683 cases and 2981 controls. However, no significant association was uncovered between the TP53 rs1042522 polymorphism and PCa susceptibility in the overall population under the five genetic models. In the stratification analysis by source of control, an increased susceptibility to PCa was identified in the population-based (P-B) group (CG vs. GG: OR = 1.48, 95% CI: 1.24â1.77, P < 0.01; CC/CG vs. GG: OR = 1.32, 95% CI: 1.12â1.57, P < 0.01), whereas a decreased susceptibility was uncovered in the hospital-based (H-B) group (CG vs. GG: OR = 0.67, 95% CI: 0.46â0.96, P = 0.03; CC/CG vs. GG: OR = 0.67, 95% CI: 0.46â0.99, P = 0.04) under heterozygous and dominant model. Conclusion: This study did not find an association between the TP53 rs1042522 polymorphism and PCa susceptibility in the overall population and corresponding subgroup analyses except in the stratification analysis by source of control. The results suggest that the TP53 rs1042522 polymorphism is not a risk factor for PCa. Keywords: TP53, rs1042522, Polymorphism, Prostate cancer, Meta-analysishttp://www.sciencedirect.com/science/article/pii/S2095882X1630127X
collection DOAJ
language English
format Article
sources DOAJ
author Song Fan
Zong-Yao Hao
Meng Zhang
Chao-Zhao Liang
spellingShingle Song Fan
Zong-Yao Hao
Meng Zhang
Chao-Zhao Liang
Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
Chronic Diseases and Translational Medicine
author_facet Song Fan
Zong-Yao Hao
Meng Zhang
Chao-Zhao Liang
author_sort Song Fan
title Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
title_short Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
title_full Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
title_fullStr Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
title_full_unstemmed Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis
title_sort association between the rs1042522 polymorphism in tp53 and prostate cancer risk: an updated meta-analysis
publisher KeAi Communications Co., Ltd.
series Chronic Diseases and Translational Medicine
issn 2095-882X
publishDate 2017-06-01
description Objective: The proposal of the present study was to investigate whether the TP53 rs1042522 polymorphism confers susceptibility to prostate cancer (PCa), by performing an updated meta-analysis. Methods: Eligible publications investigating the association between the TP53 rs1042522 polymorphism and PCa susceptibility were selected from PubMed, Google Scholar, and Web of Science. We used STATA 12.0 software to conduct the analyses. Odds ratio (OR) with 95% confidence interval (CI) was calculated. Results: A total of 17 caseâcontrol studies were retrieved reporting a total of 2683 cases and 2981 controls. However, no significant association was uncovered between the TP53 rs1042522 polymorphism and PCa susceptibility in the overall population under the five genetic models. In the stratification analysis by source of control, an increased susceptibility to PCa was identified in the population-based (P-B) group (CG vs. GG: OR = 1.48, 95% CI: 1.24â1.77, P < 0.01; CC/CG vs. GG: OR = 1.32, 95% CI: 1.12â1.57, P < 0.01), whereas a decreased susceptibility was uncovered in the hospital-based (H-B) group (CG vs. GG: OR = 0.67, 95% CI: 0.46â0.96, P = 0.03; CC/CG vs. GG: OR = 0.67, 95% CI: 0.46â0.99, P = 0.04) under heterozygous and dominant model. Conclusion: This study did not find an association between the TP53 rs1042522 polymorphism and PCa susceptibility in the overall population and corresponding subgroup analyses except in the stratification analysis by source of control. The results suggest that the TP53 rs1042522 polymorphism is not a risk factor for PCa. Keywords: TP53, rs1042522, Polymorphism, Prostate cancer, Meta-analysis
url http://www.sciencedirect.com/science/article/pii/S2095882X1630127X
work_keys_str_mv AT songfan associationbetweenthers1042522polymorphismintp53andprostatecancerriskanupdatedmetaanalysis
AT zongyaohao associationbetweenthers1042522polymorphismintp53andprostatecancerriskanupdatedmetaanalysis
AT mengzhang associationbetweenthers1042522polymorphismintp53andprostatecancerriskanupdatedmetaanalysis
AT chaozhaoliang associationbetweenthers1042522polymorphismintp53andprostatecancerriskanupdatedmetaanalysis
_version_ 1724303404118835200